Timothy Glidewell on CosMx – A Promise for Severe Aplastic Anemia
Timothy Glidewell, Spatial Regional Account Manager at Bruker Spatial, reposted from The National Institutes of Health on LinkedIn:
”The latest NCI update on an experimental therapy for severe aplastic anemia is an important signal for anyone thinking about bone marrow failure, immune dysregulation, and why only some patients respond to treatment.
To truly unravel these questions, we need to see how stem/progenitor cells, stromal support cells, and immune effectors are organized and interacting in situ.
That’s where CosMx™ Spatial Molecular Imager can help—enabling single-cell, subcellular, whole-transcriptome views of rare cell populations within the marrow niche.
These insights can support translational teams working to understand mechanisms of response and resistance in severe, immune-mediated diseases.
If you’re in the Bay Area and would like to discuss how these spatial biology platforms could support your research, feel free to reach out!”
Quoting The National Institutes of Health‘s post:
”NEWS: An NIH clinical trial has shown promise for an experimental treatment for people with severe aplastic anemia, a life-threatening disorder with limited treatments.”
Read the full announcement here.

Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications